Pluri Inc. (NASDAQ:PLUR) Short Interest Update

Pluri Inc. (NASDAQ:PLUR) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 8,600 shares, a growth of 273.9% from the October 15th total of 2,300 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 16,000 shares, the short-interest ratio is presently 0.5 days.

Pluri Price Performance

Shares of PLUR traded up $0.51 during trading hours on Wednesday, reaching $6.04. 53,177 shares of the company traded hands, compared to its average volume of 17,612. The stock has a fifty day simple moving average of $5.08 and a 200 day simple moving average of $5.44. Pluri has a fifty-two week low of $3.77 and a fifty-two week high of $8.48. The stock has a market capitalization of $33.04 million, a PE ratio of -1.00 and a beta of 1.62. The company has a quick ratio of 6.98, a current ratio of 6.98 and a debt-to-equity ratio of 4.44.

Pluri (NASDAQ:PLUR) last posted its quarterly earnings results on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. The company had revenue of $0.26 million for the quarter. Pluri had a negative return on equity of 684.77% and a negative net margin of 4,184.28%.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.